2019 Symposium

2018 Symposium

2017 Symposium

2016 Symposium

2015 Symposium

2014 Symposium

2013 Featured Talks

Previous Symposia

2018 Featured Talks » Welcome Remarks

Welcome Remarks

Thomas Kipps, MD, PhD
Symposium Chair, UC San Diego Moores Cancer Center

Thomas Kipps, MD, PhD
Symposium Chair
Distinguished Professor of Medicine
Evelyn Tasch Chair in Cancer Research
Deputy Director of Research Operations UC San Diego Moores Cancer Center

Thomas Kipps, MD, PhD, is Distinguished Professor of Medicine, Evelyn and Edwin Tasch Chair in Cancer Research, and Deputy Director of Research Operations at the UC San Diego Moores Cancer Center. He received his M.D. and Ph.D. in Immunology from Harvard University and had his residency and fellowship training in Internal Medicine, Hematology, and Genetics at Stanford University.  Dr. Kipps is internationally renowned for his translational research on immunologic approaches for the treatment of cancer and understanding the biologic mechanisms that contribute to cancer, in particular chronic lymphocytic leukemia (CLL).  Dr. Kipps has over 25 years’ experience in combining research and clinical care responsibilities, and over 380 peer-reviewed publications. Dr. Kipps directs the multi-institutional, NIH-sponsored CLL Research Consortium (CRC) and directs a Specialized Center of Research in Leukemia supported by the Leukemia & Lymphoma Society. In addition, he is a two-time awardee of the NIH MERIT Award and recipient of the Binet/Rai medal for contributions in CLL research.  He also is the principal investigator for a Disease Team III project sponsored by California Institute for Regenerative Medicine, in which he developed a humanized anti-ROR1 monoclonal antibody (mAb), designated UC-961 (or cirmtuzumab), for which he now holds the IND with which to conduct clinical trials examining the safety and efficacy of this mAb in the treatment of patients with cancer.